MedPath
NMPA Approval

Duloxetine Hydrochloride Enteric Capsules

国药准字H20223360

June 7, 2022

Drug Information

盐酸度洛西汀肠溶胶囊

胶囊剂

60mg(按C18H19NOS计)

化学药品

June 7, 2022

Company Information

Applicant Company

台州市临海市浙江省化学原料药基地临海园区

Manufacturing Company

浙江省化学原料药基地临海园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸度洛西汀肠溶胶囊 - NMPA 批准文号 | MedPath